MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
40 hedge funds and large institutions have $55.2M invested in Merrimack Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
Holders
40
Holding in Top 10
1
Calls
$3.31M
Puts
$474K
Top Buyers
| 1 | +$1.84M | |
| 2 | +$1.74M | |
| 3 | +$1.52M | |
| 4 |
Renaissance Technologies
New York
|
+$1.22M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$604K |
Top Sellers
| 1 | -$356K | |
| 2 | -$115K | |
| 3 | -$80K | |
| 4 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$43.4K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$11K |